نتایج جستجو برای: monotherapy hematopoietic

تعداد نتایج: 73323  

Journal: :hepatitis monthly 0
byung kook kim department of internal medicine, konkuk university school of medicine, konkuk university medical center, 4-12 hwayang-dong, gwangjin-gu, korea +82-220305010, [email protected] soon young ko department of internal medicine, konkuk university school of medicine, konkuk university medical center, 4-12 hwayang-dong, gwangjin-gu, korea +82-220305010, [email protected] so young kwon department of internal medicine, konkuk university school of medicine, konkuk university medical center, 4-12 hwayang-dong, gwangjin-gu, korea +82-220305010, [email protected]; department of internal medicine, konkuk university school of medicine, konkuk university medical center, 4-12 hwayang-dong, gwangjin-gu, korea +82-220305010, [email protected] eugene park department of internal medicine, konkuk university school of medicine, konkuk university medical center, 4-12 hwayang-dong, gwangjin-gu, korea +82-220305010, [email protected] jeong han kim department of internal medicine, konkuk university school of medicine, konkuk university medical center, 4-12 hwayang-dong, gwangjin-gu, korea +82-220305010, [email protected] won hyeok choe department of internal medicine, konkuk university school of medicine, konkuk university medical center, 4-12 hwayang-dong, gwangjin-gu, korea +82-220305010, [email protected]

background recently, several reports issued clevudine induced myopathy in the long term use. objectives the aim of this study was to investigate antiviral effects and adverse events of clevudine monotherapy in patients with chronic hepatitis b (chb). patients and methods the subjects were 110 treatment-naïve chb patients. they were treated with 30 mg clevudine/day for more than six months. viro...

Journal: : 2021

Aim: The aim of this study was to present the first Croatian experience with eltrombopag (a peroral thrombopoietin receptor agonist) as novel treatment option for aplastic anemia (AA). ----- Patients and Methods: This a retrospective analysis on use adult patients acquired AA among hematology centers. Results: Between 2015 2019, thirteen (nine female (69%), median age 59 (26-79) years) were tre...

2013
Ignacio Pérez-Valero Alicia González-Baeza Miriam Estébanez María L. Montes-Ramírez Carmen Bayón Federico Pulido José I. Bernardino Francisco X. Zamora Susana Monge Francisco Gaya María Lagarde Rafael Rubio Asunción Hernando Francisco Arnalich José R. Arribas

BACKGROUND In patients who remain virologically suppressed in plasma with triple-drug ART a switch to protease inhibitor monotherapy maintains high rates of suppression; however it is unknown if protease inhibitor monotherapy is associated to a higher rate of neurocognitive impairment. METHODS In this observational, cross-sectional study we included patients with plasma virological suppressio...

Journal: :Behavioural Neurology 1990

Journal: :iranian journal of blood and cancer 0
nikougoftar zarif m

cord blood hematopoietic stem cells are widely used as an alternative source for hematopoietic stem cells transplant. increasing rate of patients who need hematopoietic stem cells transplant and many advantages of cord blood in comparison to bone marrow hematopoietic stem cells, have promoted banking of cord blood units. cord blood banking requires accurate steps in donor selection, cord blood ...

Journal: :Journal of the Royal Society of Medicine 2002

Journal: :international journal of hematology-oncology and stem cell research 0
abdolkhaleg deezagi department of biochemistry, national institute of genetic engineering and biotechnology, tehran-iran neda vaseli-hagh department of biochemistry, national institute of genetic engineering and biotechnology, tehran-iran masoumeh nouri department of biochemistry, national institute of genetic engineering and biotechnology, tehran-iran

introduction: accumulating evidences indicated that during increasing of the animals' age, the number and the functional properties of hematopoietic stem cells (hscs) become altered because of a gradual decrease in replication potential.  the efficient factors in this process are dna damaging, reduced telomerase activity, shortening of telomeres and oxidative stresses. for overcoming these fact...

Journal: :international journal of hematology-oncology and stem cell research 0
ardeshir ghavamzadeh hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran roshanak derakhshandeh hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran arash jalali hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran ali jafarpour hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran kamran alimoghaddam hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran amirali hamidieh hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran

introductio: hematopoietic stem cell transplants (hsct) are considered as treatment options for patients with solid tumors. transplant numbers have changed significantly over the last decade. we have done autologous and allogeneic hsct for treatment of solid tumor patients in our center. methods: in order to show the transplant effect on solid tumor treatment, we collected data from 71 patients...

Journal: :The Journal of the American Board of Family Practice 1995
M Jerome G C Xakellis G Angstman W Patchin

BACKGROUND During the past 25 years recommendations for treating hypertension have evolved from a stepped-care approach to monotherapy or sequential monotherapy as experience has been gained and new antihypertensive agents have been introduced. In an effort to develop a disease management strategy for hypertension, we investigated the prescribing patterns of initial medication therapy for newly...

Journal: :cell journal 0

cord blood is a rich source of hematopoietic stem cells and could be potentially used for transplantation instead of conventional sources of stem cells (bone marrow or peripheral blood). cord blood cells are successfully used in pediatric and adult patients, but their major limitation is the low number of hematopoietic stem cells for patients of large body size. there are several possible solut...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید